Observation of Italian Patients with Heart Failure Being Treated with Dapagliflozin in Clinical Practice

Trial Identifier: D1699R00030
Sponsor: AstraZeneca
Collaborator:
Fullcro s.r.l.
NCTID:: NCT05250011
Start Date: April 2022
Primary Completion Date: March 2024
Study Completion Date: March 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Italy, BS Brescia, BS, Italy, 25123
Italy, CZ Catanzaro, CZ, Italy, 88100
Italy, FG Foggia, FG, Italy, 71122
Italy, FI Firenze, FI, Italy, 50100
Italy, GE Genova, GE, Italy, 16132
Italy, MB Monza, MB, Italy, 20900
Italy, MI Milano, MI, Italy, 20122
Italy, NA Napoli, NA, Italy, 80131
Italy, RM Roma, RM, Italy, 00163
Italy, RM Roma, RM, Italy, 00189
Italy, TS Trieste, TS, Italy, 34125